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Abstract
The bronchioles of the murine lung are lined by a simple columnar epithelium composed of ciliated, Clara, and goblet cells
that together mediate barrier function, mucociliary clearance and innate host defense, vital for pulmonary homeostasis. In
the present work, we demonstrate that expression of Sox2 in Clara cells is required for the differentiation of ciliated, Clara,
and goblet cells that line the bronchioles of the postnatal lung. The gene was selectively deleted in Clara cells utilizing
Scgb1a1-Cre, causing the progressive loss of Sox2 in the bronchioles during perinatal and postnatal development. The rate
of bronchiolar cell proliferation was decreased and associated with the formation of an undifferentiated, cuboidal-
squamous epithelium lacking the expression of markers of Clara cells (Scgb1a1), ciliated cells (FoxJ1 and a-tubulin), and
goblet cells (Spdef and Muc5AC). By adulthood, bronchiolar cell numbers were decreased and Sox2 was absent in extensive
regions of the bronchiolar epithelium, at which time residual Sox2 expression was primarily restricted to selective niches of
CGRP staining neuroepithelial cells. Allergen-induced goblet cell differentiation and mucus production was absent in the
respiratory epithelium lacking Sox2. In vitro, Sox2 activated promoter-luciferase reporter constructs for differentiation
markers characteristic of Clara, ciliated, and goblet cells, Scgb1a1, FoxJ1, and Agr2, respectively. Sox2 physically interacted
with Smad3 and inhibited TGF-b1/Smad3-mediated transcriptional activity in vitro, a pathway that negatively regulates
proliferation. Sox2 is required for proliferation and differentiation of Clara cells that serve as the progenitor cells from which
Clara, ciliated, and goblet cells are derived.
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Introduction
The respiratory epithelium is lined by a diversity of distinct
epithelial cell types that vary in abundance along its proximal-
distal axis. Larger cartilaginous airways (e.g. trachea and bronchi)
are lined by a pseudostratified epithelium consisting primarily of
basal, ciliated, non-ciliated secretory cells (Clara cells), and goblet
cells. Non-cartilaginous airways are lined primarily by a simple
columnar epithelium consisting of Clara and ciliated cells.
Together, the respiratory epithelium of conducting airways plays
a critical role in pulmonary homeostasis, maintaining barrier
function and sterility. The lung is continuously exposed to
particles, toxicants, and microbial pathogens that are generally
cleared from the airways by an extensive defense system, mediated
in part by mucociliary clearance, secretion of fluids, and
antimicrobial molecules, as well as by the activities of the innate
and acquired host defense systems. Cellular composition of
conducting airways varies during development, and is highly
responsive to acute and chronic injury in the postnatal lung.
Differences in cell differentiation of the conducting airways as
compared to the peripheral alveolar regions of the lung are
established early in fetal development [1,2]. The diverse cell types
lining the trachea, bronchi, bronchioles, and alveoli become highly
differentiated in the perinatal and postnatal period, during which
the respiratory epithelium is proliferative. While cell turnover and
proliferation is relatively low in the mature lung, the respiratory
epithelium is capable of extensive proliferation following injury
[3,4,5,6]. Basal and Clara cells are known to serve as progenitor
cells in the conducting airways, while type II epithelial cells
proliferate during repair of the alveoli [3,4,7]. After severe
bronchiolar injury, toxicant resistant Clara cells and bronchoal-
veolar stem cells (BASCs) residing in distinct cellular niches, also
have been proposed as relatively specialized stem cells that play a
role in repair and/or carcinogenesis [7,8]. Cellular hyperplasia
and metaplasia of the airway epithelium are associated with
common, chronic lung disorders, including those induced by
smoking, chronic obstructive pulmonary disease (COPD), asthma,
cystic fibrosis, lung cancer, and interstitial lung diseases. While
goblet cells are not highly abundant in the normal airway, goblet
cell numbers and mucus hyperproduction are commonly associ-
ated with both acute and chronic infection, allergy, and exposure
to toxicants (for example, cigarette smoke) [9,10,11,12]. Prolifer-
ation and differentiation of the diverse cells lining the respiratory
tract are influenced by complex signaling and transcriptional
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epithelium and during its repair. The roles of a number of
transcription factors, including members of the NKX, FOX,
TCF/LEF, SOX, ETS, RAR, p53/p63, Krupple-like factors, the
Notch signaling pathway, and others play a role in formation and
differentiation of the respiratory epithelium [13,14,15]. In
postnatal lung, Clara cells are capable of self-renewal and
differentiate into both ciliated cells and goblet cells, and there is
evidence that the Clara cell serves as a common progenitor of the
various cell types lining the peripheral conducting airways
[16,17,18].
The transcription factor Sox2, a member of the SRY-high
mobility box transcription factor family, is expressed in epithelial
cells of the foregut, including pharynx, esophagus, trachea,
bronchi, and bronchioles, but is excluded from the peripheral
and alveolar regions of the lung [19]. Sox2 has been implicated in
the control of differentiation in several contexts, including
maintenance of self-renewal and pluripotency in embryonic and
neural retinal stem cells, differentiation of tongue taste buds and
ear sensory cells from progenitors, and production of pluripotent
stem cells [20,21,22,23,24]. Sox2 is also expressed in developing
respiratory epithelium and is restricted to conducting airways of
the mature lung [25]. Sox2 is induced in the bronchiolar
epithelium during repair after toxicant induced injury [26].
Germline deletion of Sox2 results in blastomere death [27].
Reduction of Sox2 using hypomorphic alleles caused hearing loss,
defects in eye formation, and failure of tracheal/esophageal
separation [21,22,24,28]. Overexpression of Sox2 in lung epithe-
lium during early development disrupted branching morphogen-
esis, causing cystic lungs and neonatal death [25]. Deletion of Sox2
from primitive foregut under control of the Nkx2.5 promoter
caused malformations of the larynx and trachea, an abnormal
tracheal epithelium, and neonatal death [19]. While these data
suggest a role for Sox2 in regulating embryonic differentiation in
multiple tissues, the requirement for Sox2 in bronchiolar cells of
the postnatal lung is unknown.
To determine the role of Sox2 in differentiation and mainte-
nance of the respiratory epithelium after birth, we deleted Sox2
from mouse Clara cells beginning in late gestation. During the first
four postnatal weeks, when the mouse lung undergoes dramatic
growth, we observed progressive loss of columnar Clara, ciliated,
and goblet cells, resulting in an airway lined by a mixture of
cuboidal and squamous epithelial cells lacking morphological and
biochemical markers of normal differentiated airway. In adult
mice, Sox2 was required for the differentiation of goblet cells and
production of mucus following allergen exposure in vivo, and
activated promoter-luciferase reporters for the differentiation
markers Scgb1a1, FoxJ1, and Agr2 in vitro. Sox2 loss resulted in
reduced proliferation in vivo, and antagonized TGF-b1 signaling by
interacting with Smad3 in vitro. In spite of the loss of differentiated
ciliated, Clara, and goblet cells, mice in which Sox2 was extensively
deleted in the respiratory epithelium survived normally under
vivarium conditions. Sox2 is required for the maintenance and
differentiation of Clara, ciliated and goblet cells after birth.
Results
Localization of Sox2 in the Respiratory Epithelium
Immunohistochemical analysis was used to identify the sites of
Sox2 expression in the developing lung epithelium. A rabbit
antiserum was produced against a synthetic mouse Sox2 peptide
(aa 111 to 140). Sites of expression in the mouse embryo were
consistent with previously described sites of Sox2 mRNA. In
newborn, postnatal, and adult mice (post-natal day 0.5, 5, 28, and
42) strong nuclear staining for Sox2 was observed in all cells of the
conducting airway epithelium (Fig. 1A–D). Sox2 was absent from
the alveolar epithelium at all time points. Sox2 staining was
Figure 1. Progressive deletion of Sox2 from the bronchiolar
epithelium. In control mice, strong nuclear staining for Sox2 is
observed in all epithelial cells lining the conducting airways (A–D). Sox2
was progressively deleted from the conducting airway epithelium of
Sox2
D/D mice (E–H) from late gestation to adulthood. Arrows indicate
regions shown in insets. Scale bar is 50 mm, inset scale bar is 10 mm for
all panels. NB, newborn; PN, postnatal.
doi:10.1371/journal.pone.0008248.g001
Sox2 Regulates Progenitors
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intestinal tract (not shown), consistent with its known pattern of
expression provided by the GenePaint mRNA database [29].
Progressive Deletion of Sox2 from Lung Epithelium
Cre-recombinase was expressed under control of the rat Scgb1a1
promoter [30] to delete Sox2 from the conducting airway
epithelium. Previous studies demonstrated the activity of this
promoter in Clara cells in the conducting airway epithelium from
E16-17 and after birth [31,32]. Scgb1a1-Cre
tg/-/Sox2
flox/flox (Sox2
D/D)
mice were produced in which Sox2 was selectively and permanently
deleted from Clara cells. Since both basal and Clara cells serve
as progenitor cells in the proximal or ‘‘cartilaginous’’ airways, the
present studies were focused primarily to the role of Sox2 in the
bronchiolar regions that are lined by a simple columnar epithelium
consisting of Clara, ciliated, and a relatively smaller number of
neuroepithelial cells. To assess the effectiveness of Cre-mediated
deletion, Sox2 staining was performed on lung sections from
newborn to 6 week old mice. In newborn Sox2
D/D mice, the
numbers of Sox2 stained cells were decreased; however, both Sox2-
positive and Sox2-negative cells were detected. In control
littermates, all bronchiolar cells were Sox2-positive (Fig. 1A,E).
By postnatal day 5, Sox2 deletion was more widespread and varied
among mice. In all mice, bronchiolar regions wherein Sox2 was
absent lost their columnar characteristics, becoming cuboidal-to-
squamous in shape (Fig. 1B,F). At 4 and 6 weeks after birth,
Sox2-positive cells were occasionally observed in some lobes (not
shown). In lobes with nearly complete loss of Sox2, infrequent small
clusters of Sox2 positive cells were present (Fig. 1H). Serial lung
sections stained for Sox2 and CGRP demonstrated that these Sox2-
positive clusters were neuroendocrine cells, a cell type in which the
Scgb1a1 promoter is inactive [1]. Taken together, the progressive
loss of Sox2 in the conducting airways is consistent with the sites of
expression of Cre recombinase directed by the rat Scgb1a1
promoter [1,30,31,32].
Conditional Deletion of Sox2 Results in Cuboidal-to-
Squamous Epithelium Lacking Goblet, Clara, and Ciliated
Cells in the Conducting Airway Epithelium
The conducting airway epithelium of Sox2
D/D mice was lined
with a single layer of low cuboidal and squamous cells that lacked
the ‘‘domed’’ morphology characteristic of Clara cells, the apical
cilia characteristic of ciliated cells, or the goblet shape of mucus
producing cells (Fig. 2A–D). In adult lung, immunohistochemical
staining for Scgb1a1 (a Clara cell marker, Fig. 2E,F), FoxJ1 and
acetylated a-tubulin (ciliated cell markers, Fig. 2G–J), and Alcian
blue staining for mucins (see below) demonstrated the absence of
Clara, ciliated, and goblet cells at most sites of Sox2 deletion. The
Clara cell marker, CCSP (Scgb1a1), was lost at most sites of Sox2
deletion at birth and thereafter (Fig. 2E,F). Immunostaining for the
lung epithelial markers TTF-1 (thyroid transcription factor 1)
(Nkx2.1) and FoxA2 was not affected in Sox2
D/D airways (Fig. 2K–
N). Keratin-14 and p63 were not detected in the bronchiolar
epithelium of controls or in Sox2
D/D mice (data not shown). Co-
staining of Sox2
D/D lung sections for Sox2/Scgb1a1 and Sox2/a-
tubulin demonstrated that the majority of cells lacking Sox2 also
lacked Scgb1a1 and a-tubulin. The number of ciliated cells
expressing a-tubulin decreased with age. By six weeks of age, few
ciliated cells remained in the bronchioles of the Sox2
D/D mouse. Of
the remaining few, co-staining for Sox2 and a-tubulin demon-
strated that most were Sox2-negative (Fig. 3D). In spite of
extensive loss of normal conducting airway epithelial cells,
pulmonary inflammation was not observed in Sox2
D/D mice, and
the mice have survived normally for more than 6 months in the
vivarium.
Sox2 Is Required for Differentiation of Goblet Cells
Following Allergen Exposure
Infrequent goblet cells were observed in some large bronchioles
of four week old control mice, but were not observed in Sox2
D/D
littermates, suggesting that Sox2 is required for differentiation of
goblet cells or their precursors after birth (Fig. 4A,B). To test
whether goblet cell differentiation was inducible by allergen
exposure of Sox2
D/D mice, 6 week old Sox2
flox/flox control and
Sox2
D/D mice were sensitized to ovalbumin by intraperitoneal
injection. After three weeks of sensitization, mice received
ovalbumin by nasal aspiration and lungs were harvested when
the mice were 10 weeks old. Lung sections were immunostained
for Sox2 and co-stained with Alcian blue to identify mucin-rich
goblet cells. In control animals, dramatic goblet cell metaplasia,
with strong staining for Muc5AC and nuclear Sox2 and Spdef was
observed in bronchi and larger bronchioles (Fig. 4C,E,G). In
contrast, goblet cells were absent in Sox2
D/D bronchiolar
epithelium. Neither Spdef (an Ets-like factor required for goblet
cell differentiation) nor Muc5AC (a pulmonary mucin) were
induced (Fig. 4F,H). Rare clusters of Sox2-positive goblet cells
were observed in some large airways of Sox2
D/D lungs, where they
were associated with incomplete Sox2 deletion (asterisk in Fig. 4D),
while inflammation was evident in both control and Sox2
D/D mice.
These results demonstrate that Sox2 is required for goblet cell
differentiation during allergen challenge.
Reduced Proliferation and Decrease in Cell Density in the
Bronchioles of Sox2
D/D Mice
Murine lung undergoes rapid growth in the first four weeks of
life. At 4 weeks of age, immunohistochemical staining for the
proliferation marker Ki-67 demonstrated a significant decrease
(42%) in the proliferative index in Sox2
D/D mice. To assess whether
cell shape was changed, morphometric analysis was performed.
Cell width increased 13%, cell height decreased 33%, and cell
density decreased 12% compared to controls (p,.001), consistent
with the shift from columnar to the cuboidal-squamous morphol-
ogy seen histologically (Fig. 5). Sox2 deletion did not result in
increased apoptosis, as measured by immunohistochemical
staining for cleaved Caspase 3 (data not shown).
Sox2 Activates Promoter-Luciferase Constructs for
Scgb1a1, FoxJ1, and Agr2
Since the deletion of the Sox2 gene resulted in a loss of
differentiation, we sought to identify a mechanism by which Sox2
influenced differentiation. Nkx2.1 and FoxA2 are known regulators
of respiratory epithelial differentiation markers, and normal
expression levels of these transcription factors were observed in
Sox2
D/D mice. To test the hypothesis that Sox2 is required for
Nkx2.1 or FoxA2 activity, promoter-luciferase reporter assays were
performed using Sox2 alone and Sox2 plus Nkx2.1 or FoxA2. Sox2
alone induced activation of the Scgb1a1, FoxJ1, and Agr2 promoters
(Fig. 6A,B,C), markers of the Clara cell, ciliated cell, and goblet cell,
respectively. While synergistic activation of the Scgb1a1 promoter by
Nkx2.1 and FoxA2 was observed (Fig. 6A), combination of Sox2
with Nkx2.1 or FoxA2 resulted in additive but not synergistic
activation (Fig. 6A,B,C). Sox2, Nkx2.1, and FoxA2 (alone or in
combination) did not activate a Spdef-luciferase construct (data not
shown). Taken together, these data demonstrate that Sox2 is a
positive regulator of selected markers of differentiation, but not a
synergistic partner of Nkx2.1 or FoxA2.
Sox2 Regulates Progenitors
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Signaling
Since the loss of Sox2 resulted in decreased bronchiolar cell
proliferation, we sought to identify a mechanism by which Sox2
influenced cell proliferation. Sox17, another member of the Sox
family of transcription factors, promotes proliferation, in part by
direct binding to Smad3, thus blocking TGF-b induced cell cycle
repression [33]. Since TGF-b/Smad signaling is a major anti-
proliferative pathway in multiple epithelial cell types, and is active
in the postnatal mouse bronchiolar epithelium [34], we tested the
Figure 2. Lack of ciliated and Clara cell selective markers after deletion of Sox2. In four week old mice, hematoxylin and eosin staining of
control and Sox2
D/D lung sections demonstrated abnormal low cuboidal-to-squamous epithelium in large bronchioles (A, B) and small bronchioles
(C,D). Immunohistochemical staining demonstrated loss of CCSP (Scgb1a1) a Clara cell marker (E,F), ciliated cell markers a-tubulin and FoxJ1 (G–J).
Lung epithelial markers Nkx2.1 and FoxA2 were unchanged in control vs Sox2
D/D mice (K–N). Arrows indicate regions shown in insets. Scale bar is
50 mm, inset scale bar is 10 mm.
doi:10.1371/journal.pone.0008248.g002
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Sox2 inhibited TGF-b1 and Smad3 induced activation of a 3TP
luciferase reporter construct in HBECs (Fig. 7A,C). Coimmuno-
precipitation assays demonstrated that Sox2 forms a complex with
Smad3 (Fig. 7B). Taken together, these data provide a potential
mechanism by which loss of Sox2 may influence cell proliferation.
Discussion
Deletion of Sox2 from Clara cells in the postnatal bronchiolar
epithelium caused the progressive loss of ciliated, Clara, and goblet
cells and an inability to produce goblet cells in response to allergen
challenge. Taken together, expression of Sox2 in Clara cells is
required for differentiation and/or maintenance of ciliated, Clara,
and goblet cells in bronchiolar epithelium after birth. The findings
support the concept that Clara cells serve as the common
progenitors of ciliated, Clara, and goblet cells in a process
requiring Sox2. Remarkably, Sox2
D/D mice survive normally in the
vivarium in spite of the widespread loss of ciliated, Clara, and
goblet cells from conducting airways.
The Clara cell of the intrapulmonary airway is capable of self-
renewal and transdifferentiation into ciliated and goblet cells
[16,17,18], and has been termed a facultative progenitor in lung
homeostasis [35]. In the present study, we utilized the rat Scgb1a1
promoter that is specifically active in Clara but not in ciliated or
neuroepithelial cells. The loss of Clara, ciliated and goblet cells in
response to Sox2 deletion are consistent with the proposed role of
Clara cells as progenitor cells in bronchioles, and show that Sox2 is
necessary for normal proliferation and differentiation of the major
epithelial cell types lining the bronchioles (Fig. 8).
Experiments observing the steady-state pattern of chimeric
labeled mouse embryonic stem cells [36], and pulse-lineage-labeled
Figure 3. Maintenance of Sox2 expression in neuroepithelial cells. Immunofluorescence staining of six week old Sox2
D/D mice demonstrated
Sox2-positive ciliated and Clara cells in control mice (A,C), the extensive deletion of Sox2, and the presence of rare ciliated and Clara cells lacking Sox2
in Sox2
D/D mice (B,D). Serial sections from Sox2
D/D mice (E,F) identified a cluster of more cuboidal, untargeted cells which stained for Sox2 (E) and a
distinct subset of Sox2 reactive cells expressing the neuroendocrine cell marker CGRP in which the Scgb1a1 promoter is not active (F). Arrows indicate
regions shown in insets. Scale bars: 20 mm (A–D), 40 mm (E,F). Inset scale bars: 5 mm (A–D), 10 mm (E,F).
doi:10.1371/journal.pone.0008248.g003
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intrapulmonary respiratory epithelium, most progenitor cells (e.g.
Clara cells) are randomly distributed throughout the bronchioles
and are not associated with particular anatomical niches. Interest-
ingly, unlike bronchiolar Clara cells, numbers of tracheal Clara cells
that were labeled with a conditional Cre-ER in the newborn period,
steadily declined as the mice aged. Thus, progenitor cell activity in
the trachea may be somewhat different than that in the bronchioles
[17], findings consistent with previous studies demonstrating the
importance of tracheal basal cells as progenitors during repair
[5,37,38]. Epithelial cells in the submucosal glands and basal cells in
larger airways are able to contribute to epithelial repair. Although
recent studies demonstrate that progenitor cells in rare anatomical
niches were not responsible for bronchiolar maintenance, there is
evidence that they play a role in lung repair after extensive injury
[36,37,38]. Bronchio-alveolar stem cells (BASCs) have been
proposed as a uniquely proliferative stem cell [7,8], although recent
evidence supports the concept that Clara cells or toxicant resistant
Clara cells are the primary progenitors during repair of the
postnatal lung airway [36,39].
The present study and recent findings, in which Sox2 was
deleted in the embryonic lung and trachea, support the concept
that progenitor cell relationships are somewhat distinct in the
proximal and peripheral airways. An Nkx2.5-Cre construct was
used recently to delete Sox2 from the ventral epithelial domain of
the anterior foregut prior to lung budding and the consequences
on tracheal development were examined [19]. The deletion of
Sox2 using Nkx2.5 occurred earlier than in the present model and
resulted in abnormal laryngeal/tracheal cartilage formation and
perinatal death. In that study, a small subset of tracheal cells
lacked markers of differentiation and numbers of tracheal Clara
and ciliated cells were reduced. In contrast to findings in the
present study, increased numbers of tracheal goblet cells were
observed and tracheal proliferation was normal following the early
deletion of Sox2 from the embryo [19]. In the present study, Sox2
was deleted in the perinatal/postnatal period, after lung branching
morphogenesis was complete, and its consequences on postnatal
growth and allergen challenge were examined. Perinatal deletion
of Sox2 resulted in progressive loss of both ciliated and Clara cells
in the bronchiolar epithelium. In response to the allergen, goblet
cell differentiation was absent in the Scgb1a1-Cre Sox2
D/D mice in
spite of extensive inflammation. Goblet cells were absent at
baseline and after allergen challenge as indicated by mucin,
Muc5AC, and Spdef staining in the bronchioles of the Scgb1a1-Cre
Sox2
D/D mice. The significant temporal and spatial differences in
which Sox2 was deleted are likely responsible for the differences in
goblet cell differentiation seen in these two systems.
A tamoxifen-inducible CMV-CreER construct was used recently
to delete Sox2 in adult mice and its effect on tracheal homeostasis
studied [19]. In the adult tracheal epithelium, reduced cell
proliferation and cell height and increased cell width were
observed. In the trachea, numbers of Clara cells were not reduced
after deletion of Sox2, perhaps indicating the importance of basal
cells to the homeostasis of pseudostratified epithelium of the
proximal airway. Recent lineage analysis of Clara cells in the
trachea and bronchioles support their role in bronchiolar
homeostasis, but not in the trachea where other cell types,
presumably basal cells, play an important role.
Figure 4. Sox2 is required for goblet cell differentiation after pulmonary allergen sensitization. Lung sections from normal four week
old mice were co-stained for mucins with Alcian blue and Sox2 demonstrating the presence of goblet cells in the airways of control mice (A) but not
in Sox2
D/D littermates (B). Response to allergen challenge (C–H): In control mice, Alcian blue reactive cells expressed Sox2 (C,D), and the goblet cell
associated proteins Spdef (E,F) and Muc5AC (G,H). Extensive goblet cell differentiation was observed in bronchi and larger bronchioles of control
(C,E,G) but not Sox2
D/D mice (D,F,H), in spite of the robust inflammatory response seen in both groups. Asterisk in D indicates a small cluster of Sox2-
positive (untargeted) goblet cells. Arrows indicate regions shown in insets. Scale bar is 50 mm, inset scale bar is 10 mm. OVA+, ovalbumin treatment.
doi:10.1371/journal.pone.0008248.g004
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[16,17], and ciliated cells are long-lived [40]. In the present mouse
model, the progressive loss of Clara cells occured during the rapid
growth phase (0–4 wks) and was faster than loss of ciliated cells, as
indicated by the expression of FoxJ1 and a-tubulin. The lack of
cleaved Caspase 3 staining after deletion of Sox2 suggests that the
loss of cell number is not related to apoptosis. Thus it is likely that
the progressive loss of the columnar morphology is mediated by
the decreased proliferation, the gradual loss of ciliated cells that
were differentiated before the deletion of Sox2 in their progenitors
(Clara cells) and the rapid loss of differentiated features of Clara
cells after deletion of Sox2. These findings suggest that Sox2 plays a
role in Clara cell differentiation, proliferation and progenitor cell
capacity.
The deletion of Sox2 from the bronchial epithelium did not
influence the expression of Nkx2.1 or Foxa2, transcription factors
important for the expression of differentiation markers. Thus the
loss of the Clara cell marker Scgb1a1 (a direct target of both
Nkx2.1 and Foxa2) is not caused by the loss of Nkx2.1 or FoxA2.
In the present study, in vitro promoter assays demonstrated that
Sox2 was not a synergistic partner of Nkx2.1 or FoxA2 in the
activation of Scgb1a1. The ubiquitous presence of Sox2 in normal
Clara, ciliated, and goblet cells, and the activation of the Scgb1a1,
FoxJ1, and Agr2 promoter-luciferase constructs by Sox2 support
the role of Sox2 as a positive regulator of these differentiation
markers. Taken together, the results demonstrate that Sox2 is
necessary for differentiation and maintenance of Clara, ciliated,
and goblet cells from Clara cell progenitors, and may play a role in
directly regulating the expression of differentiation dependent
genes in each of these cell types. Recent studies demonstrated the
loss of both Nkx2.1 and FoxA2 during allergen induced
differentiation of goblet cells [18]. The lack of goblet cells during
allergen challenge to Sox2
D/D mice supports the concept that Clara
cell differentiation, dependent upon Sox2, is required for the
Figure 5. Decreased proliferation and decreased cell density after deletion of Sox2. Bronchiolar cells were co-stained for Sox2 (green) and
Ki-67 (red). Average cell height, cell density, and proliferation index was assessed by morphometric analysis (A,B,C). Representative bronchiolar
epithelium of control (D) and Sox2
D/D (E) are shown in side view (upper portion) and plan view (lower portion). Graphs depict mean6standard error
of the mean.
doi:10.1371/journal.pone.0008248.g005
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exposure. The bronchiolar epithelium of the Sox2
D/D mice lacked
both Muc5AC and Spdef (Fig. 4E–H). Perhaps consistent with the
requirement for Sox2 in goblet cell differentiation, Sox2 activated
a Muc5AC-luciferase reporter in colorectal tumors [41], and Muc5B
mRNA was increased in lung when Sox2 was overexpressed in a
transgenic mouse model [25].
In the present study, cell proliferation was significantly reduced
in the bronchioles after perinatal deletion of Sox2 using a Scgb1a1-
Cre transgene, a finding consistent with reduced cell proliferation
seen in the adult trachea after deletion of Sox2 from mature
trachea using an CMV-CreER transgene [19]. While mechanisms
controlling its role in bronchiolar cell proliferation are unclear at
present, Sox2 promotes proliferation in breast cancer cell lines
[42] and the loss of Sox2 promotes terminal differentiation of
neuronal stem cells [43]. The functions of Sox2 are highly
dependent on cell types and developmental cassettes. Sox2
mediates cellular reprogramming required for pluripotent stem
cell activity in fibroblasts. Sox2 interacts with multiple transcrip-
tional partners and co-activators that are influenced by develop-
mental, cellular, and tissue dependent factors. TGF-b/Smad3
signaling is a potent anti-proliferative pathway in multiple
epithelial types, including respiratory epithelial cells, and
promotes squamous differentiation of bronchiolar epithelial cells
in vitro [44]. In the present study, we observed that Sox2, like
Sox17, bound to Smad3 and inhibited its activity, providing a
potential mechanism by which Sox2 may influence cell prolifer-
ation and differentiation.
Summary
In summary, the expression of Sox2 in Clara cells of the
bronchiolar epithelium was required for its normal differentiation
Figure 6. Sox2 induced promoter activity for differentiation markers Scgb1a1, FoxJ1, and Agr2. HBECs were transfected with (A) Scgb1a1-
luciferase reporter (0.5 mg), (B) FoxJ1-luciferase reporter (0.5 mg), or (C) Agr2-luciferase reporter (0.5 mg) in the presence of various combinations of
Sox2 (0.1 mg), Nkx2.1 (0.1 mg), and FoxA2 (0.1 mg). Sox2 induced modest activation of Scgb1a1, FoxJ1, and Agr2 (A,B,C). Synergistic activation of
Scgb1a1 by Nkx2.1 and FoxA2 was observed (A). Sox2 did not synergize with Nkx2.1 or FoxA2 to regulated Scgb1a1, FoxJ1,o rAgr2 constructs. Graphs
depict representative results of 3 separate experiments performed in triplicate, and are expressed as the mean6standard deviation.
doi:10.1371/journal.pone.0008248.g006
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importance of both Sox2 and Clara cells (the latter serving as
facultative progenitors of Clara, ciliated, and goblet cells) in
proximal airway differentiation and homeostasis. Sox2 was
required for the expression of Spdef, a gene required for postnatal
goblet cell differentiation and mucus hyperproduction in response
to pulmonary allergen sensitization. In spite of the extensive loss of
Clara, ciliated, and goblet cells, mice in which Sox2 was extensively
deleted from the respiratory epithelium do not develop spontane-
ous infections and survive normally in the vivarium, indicating an
unexpected compensatory capacity in the maintenance of
homeostasis in spite of extensive changes to the structure of the
conducting airway.
Materials and Methods
Transgenic Animals
The Sox2
floxed allele was generated in an SV129 background by
flanking the single exon of the endogenous Sox2 allele with loxP
sites via homologous recombination [45]. The Scgb1a1-Cre
transgenic mouse [46] was kindly provided by Dr. Steven
Shapiro (Pittsburg, PA) and maintained on a SV129/C57Bl6
ba c kg ro u n d.Mi cew e recr o sse dtopro d u ceScgb1a1Cre/Sox2
flox/flox
mutants with Scgb1a1-Cre,a n dSox2
flox/flox control littermates.
No morphologic or histologic differences were observed between
the Scgb1a1-Cre and Sox2
flox/flox mice. Mice of all genotypes
survived normally after birth and up to 6 months of age in our
vivarium.
Animal Husbandry
Mice were maintained in a pathogen-free environment in
accordance with protocols approved by the Institutional Animal
Care and Use Committee of the Cincinnati Children’s Hospital
Research Foundation. Food and water were provided ad libitum in
temperature-controlled isolation cages on a 14 hr light/10 h dark
cycle. There was no serological evidence of pulmonary pathogens
or bacterial infections in sentinel mice maintained within the
colony.
Figure 7. Sox2 inhibited TGF-b1 sensitive promoter activity reporter assay and co-immunoprecipitated with Smad3. (A) HBECs were
transfected with a TGF-b1/Smad-responsive reporter 3TP-luciferase (3TP-Luc) and increasing amounts of pCIG empty vector or pCIG-Sox2 (0.25 mg
and 0.5 mg) in the presence or absence of TGF-b1 (2 ng/ml). Sox2 inhibits TGF-b1-mediated reporter activation. (B) Coimmunoprecipitations
performed on lysates from HBECs expressing Sox2-V5 and FLAG-Smad3 demonstrated an interaction between Sox2 and Smad3. (C) Sox2 inhibits
Smad3-induced activation of 3TP-Luc in the presence or absence of TGF-b1 in HBECS. IP, immunoprecipitation; IB, immunoblot; IgG, immunoglobulin
negative control. Graphs depict representative results from three experiments6standard deviation of the mean.
doi:10.1371/journal.pone.0008248.g007
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Tissue harvesting was preceded by administration of 0.1 mL
anesthetic (ketamine, xylazine, and acepromazine) and then
exsanguination by severing the inferior vena cava. Mouse lungs
obtained on postnatal day 5 and thereafter were inflation fixed by
gravity with 4% PFA (paraformaldehyde in phosphate buffered
saline (PBS)(20 mM Tris?HCl, pH 7.6, 137 mM NaCl)) at 25 cm
hydrostatic pressure for 1 minute. Embryonic and adult lungs were
immersed overnight in 4% PFA at 4uC, washed in PBS followed
by dehydration in a series of ethanol solutions prior to paraffin
embedding. Paraffin sections were melted in a 60uC oven and
deparaffinized in xylene, followed by rehydration in ethanol
washes. Peroxidase treatment in methanol with 0.5% hydrogen
peroxide was followed by heat-assisted antigen retrieval in 0.01 M
sodium citrate buffer (pH 6.0). Blocking was performed for 2 hrs
at room temperature using 4% goat or 4% donkey serum followed
by overnight incubation with primary antibody at 4uC. Antibodies
used were Sox2 (WRAB-Sox2, 1:2000, Seven Hills Bioreagents,
Cincinnati, OH), Scgb1a1 (WRAB-Ccsp, 1:4000, Seven Hills
Bioreagents), Nkx2.1 (WRAB-Ttf1, 1:2000, Seven Hills Biorea-
gents), FoxA2 (WRAB-FoxA2, 1:5000, Seven Hills Bioreagents),
FoxJ1 (generated internally, 1:6000), acetylated a-tubulin (catalog
T7451 Clone6-11B-1, IgG2b, 1:2000, Sigma, St Louis, MO),
Keratin-14 (Clone LL002, IgG3, 1:100, Neomarkers, Fremont,
CA), p63 (sc-8344, 1:200, Santa Cruz Biotechnology Inc., Santa
Cruz, CA), Ki-67 (m7249, 1:500 Dako, Carpintera, CA), CGRP
(catalog 8198, 1:3000, Sigma), and cleaved Caspase 3 (1:1000,
rabbit polyclonal; R&D Systems, Inc., Minneapolis, MN). Rinsed
sections were incubated with biotinylated secondary antibodies
directed to primary antibody host IgGs (7.5 ug/ml; Vector
Laboratories, Burlingame CA), visualized with the Vectastain
Elite ABC kit (Vector Laboratories, Burlingame, CA) using nickel-
diaminobenzidine as a substrate, enhanced with Tris-cobalt, and
counterstained with 0.1% nuclear-fast red. Rabbit polyclonal
antibody was generated against a fragment of synthetic mouse
Sox2 protein (aa 111–140) conjugated to keyhole limpet
hemocyanin. Peptide synthesis and conjugation were performed
by AnaSpec Inc. (San Jose, CA). Immunohistofluorescence was
performed on 5-mm-thick sections using antibodies generated to
Sox2 (1:200), CCSP (1:2000, goat polyclonal, sc-9772), acetylated
a-tubulin (1:2000), Ki-67 (1:100), and secondary antibodies
conjugated with Alexa Fluor 594, Alexa Fluor 488 fluorochromes
(1:200, Molecular Probes, Invitrogen Corp., Carlsbad, CA). The
slides were examined by microscopy using dual fluorescent
labeling and a Zeiss Axioplan 2 Imaging Universal Microscope
with an Axiocam MRm black and white digital camera (Axiovision
Release 4.3).
Pulmonary Allergen Exposure
At approximately 6 weeks of age, Sox2
D/D (n=6) and control
(n=5) mice were sensitized by intraperitoneal injection of 0.1 mg
ovalbumin (OVA, Sigma, grade V) and 1 mg aluminum
hydroxide adjuvant (alum) on days 0 and 14. Intranasal treatment
with 50 mg OVA was performed on days 25 and 28 as previously
described [47]. Lungs were harvested on day 30.
Cell Proliferation and Density
Immunofluorescence staining for Sox2 and for the proliferation
marker Ki-67 was performed on lung sections from 4 week old
Sox2
D/D (n=3) and control (n=3) mice. At least 8–12 images
containing a total of 200 cells and approximately 1400–1500 um
of bronchiolar epithelium, were examined at a magnification of
40X for each of the Sox2
D/D mice; and 7–8 images, containing 200
cells and approximately 1200–1300 um of bronchiolar epithelium
Figure 8. Model in which Sox2 is required for Clara cell self renewal and differentiation of facultative progenitors of the bronchiolar
epithelium. (A) The Clara cell is postulated to be the facultative progenitor cell of the bronchiolar epithelium, possessing differentiated cell
characteristics yet capable of self-renewal and differentiation into ciliated or goblet cells. (B) Loss of Sox2 from Clara cells results in an epithelium
lacking differentiated cells, consistent with the Clara/facultative stem cell model. Sox2 is required for normal proliferation during perinatal growth and
for the postnatal differentiation of Clara, ciliated, and goblet cells in the bronchiolar epithelium.
doi:10.1371/journal.pone.0008248.g008
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number of Ki-67 positive cells, and length of bronchiolar
epithelium examined were obtained from contiguous Sox2-
negative cells for the Sox2
D/D mice. Cell counts and bronchiolar
epithelial lengths were determined using MetaMorphH imaging
software (Molecular Devices, Downingtown, PA). Cell width,
height, and density were calculated from the raw data measure-
ments. Statistical differences were assessed by the Student’s t test
when data were normally distributed or by the Mann-Whitney
Rank Sum test when data did not meet equal variance or normal
distribution criteria.
Plasmids
The pCIG-Sox2 (mouse cDNA) plasmid and pcDna6.1-Sox2-
V5 epitope-tagged (mouse cDNA) construct were kind gifts from
Dr. Aaron Zorn and Dr. James Wells [48]. The 3TP-luciferase
(3TP-Luc) TGF-b/Smad reporter plasmid was obtained from Dr.
Jeff Molkentin (Cincinnati Children’s Hospital Research Founda-
tion), and the FLAG-Smad3 expression vector (Addgene plasmid
14052) was generated by Dr. Joan Massague (Memorial Sloan-
Kettering Cancer Center) [49]. The reporter plasmids, Scgb1a1-
luciferase (2.3 kb rat Scgb1a1 promoter-pGL2), FoxJ1-luciferase
(3.4 kb mouse FoxJ1 promoter-pGl3), Agr2-luciferase (1.6 kb mouse
Agr2 promoter-pGl3), Spdef-luciferase (2.8 kb mouse Spdef promoter-
pGl3), express the luciferase gene under control of each promoter.
The expression plasmids pRc/CMV-Nkx2.1 (rat cDNA) and pRc/
CMV-FoxA2 (rat cDNA) have been previously described [50,51].
Cell Culture and TGF-b Reporter Assay
Immortalized Human Bronchial Epithelial Cells (HBECs) were
maintained as previously described [52]. HBECs were seeded in 6-
well culture plates at 1610
5 cells per well and transfected using
FuGENE6 (Roche). Empty vectors (pCIG or pcDna6.1) and
pCMV-b-galactosidase vectors (Clontech) were used to normalize
total DNA and transfection efficiency, respectively. Recombinant
human TGF-b1 (2 ng/ml; R&D Systems) was added directly to
the culture medium where indicated. Cells were harvested 24 h
post-transfection and luciferase activity was measured using a
Luciferase Assay System kit (Promega) and normalized to b-
galactosidase activity. Experiments were performed three times in
triplicate and statistical significance was determined using paired
Student’s t test.
Co-Immunoprecipitation of Smad3 and Sox2
HBECs were seeded in 10 cm plates and transfected at ,70–
80% confluence with Sox2-V5 and FLAG-Smad3 expression
vectors using FuGENE6 transfection reagent (Roche). Cells were
harvested 24 h post-transfection and lysed for 30 min at 4uCi n
NETN buffer (20 mM Tris, pH 8.0; 100 mM NaCl; 1 mM
EDTA; 0.5% NP-40; 1 mM PMSF; 10 mM beta-glycerophos-
phate; 10 ml/ml Protease Inhibitor Cocktail, Sigma). Lysates were
precleared using Protein A/G PLUS agarose beads (Santa Cruz)
for 1–2 h at 4uC and 4% of the precleared lysate volume was kept
as input. Immunoprecipitations were performed using equal
volumes of the precleared lysate incubated with EZ view Red
Anti-FLAG M2 Affinity gel (Sigma) or Protein A/G PLUS agarose
beads (Santa Cruz) and rabbit anti-Sox2 (WRAB-Sox2, Seven
Hills Bioreagents, 3 ml) or normal rabbit IgG (1.5 mg; Santa Cruz).
After several washes with NETN buffer, samples were eluted by
boiling in Laemmli sample buffer including b-ME and subjected to
SDS-PAGE. Immunoblots were performed using mouse anti-
FLAG-HRP (1:1000; Sigma) and mouse anti-V5-HRP (1:2500;
Invitrogen) antibodies and developed using ECL reagents.
Acknowledgments
The authors wish to thank Ann Maher, Paula Blair, William Hull, Gail
Macke, and David Loudy for their assistance.
Author Contributions
Conceived and designed the experiments: DHT VB AWL ARK ANS RL
JAW. Performed the experiments: DHT AWL ARK. Analyzed the data:
DHT VB AWL SEW ARK JAW. Wrote the paper: DHT VB AWL SEW
RL JAW. Immunohistochemistry: VB.
References
1. Perl AK, Wert SE, Loudy DE, Shan Z, Blair PA, et al. (2005) Conditional
recombination reveals distinct subsets of epithelial cells in trachea, bronchi, and
alveoli. Am J Respir Cell Mol Biol 33: 455–462.
2. Perl AK, Wert SE, Nagy A, Lobe CG, Whitsett JA (2002) Early restriction of
peripheral and proximal cell lineages during formation of the lung. Proc Natl
Acad Sci U S A 99: 10482–10487.
3. Evans MJ, Cabral LC, Stephens RJ, Freeman G (1974) Acute kinetic response
and renewal of the alveolar epithelium following injury by nitrogen dioxide.
Chest 65: Suppl: 62S–65S.
4. Evans MJ, Cabral LJ, Stephens RJ, Freeman G (1975) Transformation of
alveolar type 2 cells to type 1 cells following exposure to NO2. Exp Mol Pathol
22: 142–150.
5. Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR (2004) Basal cells are a
multipotent progenitor capable of renewing the bronchial epithelium.
Am J Pathol 164: 577–588.
6. Schoch KG, Lori A, Burns KA, Eldred T, Olsen JC, et al. (2004) A subset of
mouse tracheal epithelial basal cells generates large colonies in vitro. Am J Physiol
Lung Cell Mol Physiol 286: L631–642.
7. Giangreco A, Reynolds SD, Stripp BR (2002) Terminal bronchioles harbor a
unique airway stem cell population that localizes to the bronchoalveolar duct
junction. Am J Pathol 161: 173–182.
8. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, et al. (2005)
Identification of bronchioalveolar stem cells in normal lung and lung cancer.
Cell 121: 823–835.
9. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, et al. (2004) The nature
of small-airway obstruction in chronic obstructive pulmonary disease.
N Engl J Med 350: 2645–2653.
10. Holgate ST, Polosa R (2006) The mechanisms, diagnosis, and management of
severe asthma in adults. Lancet 368: 780–793.
11. Rogers DF (1994) Airway goblet cells: responsive and adaptable front-line
defenders. Eur Respir J 7: 1690–1706.
12. Rose MC, Voynow JA (2006) Respiratory tract mucin genes and mucin
glycoproteins in health and disease. Physiol Rev 86: 245–278.
13. Maeda Y, Dave V, Whitsett JA (2007) Transcriptional control of lung
morphogenesis. Physiol Rev 87: 219–244.
14. Costa RH, Kalinichenko VV, Lim L (2001) Transcription factors in mouse lung
development and function. Am J Physiol Lung Cell Mol Physiol 280: L823–838.
15. Warburton D, Schwarz M, Tefft D, Flores-Delgado G, Anderson KD, et al.
(2000) The molecular basis of lung morphogenesis. Mech Dev 92: 55–81.
16. Evans MJ, Cabral-Anderson LJ, Freeman G (1978) Role of the Clara cell in
renewal of the bronchiolar epithelium. Lab Invest 38: 648–653.
17. Rawlins EL, Okubo T, Xue Y, Brass DM, Auten RL, et al. (2009) The role of
Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway,
but not alveolar, epithelium. Cell Stem Cell 4: 525–534.
18. Chen G, Korfhage TR, Xu Y, Kitzmiller J, Wert SE, et al. (2009) Spdef is
required for pulmonary goblet cell differentiation and regulates a network of
genes associated with mucus production (in press). Journal of Clinical
Investigation.
19. Que J, Luo X, Schwartz RJ, Hogan BL (2009) Multiple roles for Sox2 in the
developing and adult mouse trachea. Development 136: 1899–1907.
20. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, et al. (2005) Core
transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:
947–956.
21. Dabdoub A, Puligilla C, Jones JM, Fritzsch B, Cheah KS, et al. (2008) Sox2
signaling in prosensory domain specification and subsequent hair cell
differentiation in the developing cochlea. Proc Natl Acad Sci U S A 105:
18396–18401.
22. Kiernan AE, Pelling AL, Leung KK, Tang AS, Bell DM, et al. (2005) Sox2 is
required for sensory organ development in the mammalian inner ear. Nature
434: 1031–1035.
23. Okubo T, Pevny LH, Hogan BL (2006) Sox2 is required for development of
taste bud sensory cells. Genes Dev 20: 2654–2659.
Sox2 Regulates Progenitors
PLoS ONE | www.plosone.org 11 December 2009 | Volume 4 | Issue 12 | e824824. Taranova OV, Magness ST, Fagan BM, Wu Y, Surzenko N, et al. (2006) SOX2
is a dose-dependent regulator of retinal neural progenitor competence. Genes
Dev 20: 1187–1202.
25. Gontan C, de Munck A, Vermeij M, Grosveld F, Tibboel D, et al. (2008) Sox2 is
important for two crucial processes in lung development: branching morpho-
genesis and epithelial cell differentiation. Dev Biol 317: 296–309.
26. Park KS, Wells JM, Zorn AM, Wert SE, Laubach VE, et al. (2006)
Transdifferentiation of ciliated cells during repair of the respiratory epithelium.
Am J Respir Cell Mol Biol 34: 151–157.
27. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, et al. (2003) Multipotent
cell lineages in early mouse development depend on SOX2 function. Genes Dev
17: 126–140.
28. Que J, Okubo T, Goldenring JR, Nam KT, Kurotani R, et al. (2007) Multiple
dose-dependent roles for Sox2 in the patterning and differentiation of anterior
foregut endoderm. Development 134: 2521–2531.
29. GenePaint. An atlas of gene expression patterns in the mouse embryo. Available
at http://www.genepaint.org. Accessed March 1, 2009.
30. Stripp BR, Sawaya PL, Luse DS, Wikenheiser KA, Wert SE, et al. (1992) cis-
acting elements that confer lung epithelial cell expression of the CC10 gene.
J Biol Chem 267: 14703–14712.
31. Reynolds SD, Zemke AC, Giangreco A, Brockway BL, Teisanu RM, et al.
(2008) Conditional stabilization of beta-catenin expands the pool of lung stem
cells. Stem Cells 26: 1337–1346.
32. Zemke AC, Teisanu RM, Giangreco A, Drake JA, Brockway BL, et al. (2009)
{beta}-Catenin is not Necessary for Maintenance or Repair of the Bronchiolar
Epithelium. Am J Respir Cell Mol Biol 41: 535–543.
33. Lange AW, Keiser AR, Wells JM, Zorn AM, Whitsett JA (2009) Sox17 promotes
cell cycle progression and inhibits TGF-beta/Smad3 signaling to initiate
progenitor cell behavior in the respiratory epithelium. PLoS ONE 4: e5711.
34. Alejandre-Alcazar MA, Michiels-Corsten M, Vicencio AG, Reiss I, Ryu J, et al.
(2008) TGF-beta signaling is dynamically regulated during the alveolarization of
rodent and human lungs. Dev Dyn 237: 259–269.
35. Stripp BR (2008) Hierarchical organization of lung progenitor cells: is there an
adult lung tissue stem cell? Proc Am Thorac Soc 5: 695–698.
36. Giangreco A, Arwert EN, Rosewell IR, Snyder J, Watt FM, et al. (2009) Stem
cells are dispensable for lung homeostasis but restore airways after injury. Proc
Natl Acad Sci U S A 106: 9286–9291.
37. Hsia CC (2004) Signals and mechanisms of compensatory lung growth. J Appl
Physiol 97: 1992–1998.
38. Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR (2004) In vivo
differentiation potential of tracheal basal cells: evidence for multipotent and
unipotent subpopulations. Am J Physiol Lung Cell Mol Physiol 286: L643–649.
39. Reynolds SD, Hong KU, Giangreco A, Mango GW, Guron C, et al. (2000)
Conditional clara cell ablation reveals a self-renewing progenitor function of
pulmonary neuroendocrine cells. Am J Physiol Lung Cell Mol Physiol 278:
L1256–1263.
40. Rawlins EL, Hogan BL (2008) Ciliated epithelial cell lifespan in the mouse
trachea and lung. Am J Physiol Lung Cell Mol Physiol 295: L231–234.
41. Park ET, Gum JR, Kakar S, Kwon SW, Deng G, et al. (2008) Aberrant
expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous
cancers of the colorectum and related lesions. Int J Cancer 122: 1253–1260.
42. Chen Y, Shi L, Zhang L, Li R, Liang J, et al. (2008) The molecular mechanism
governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem 283:
17969–17978.
43. Kondo T, Raff M (2004) Chromatin remodeling and histone modification in the
conversion of oligodendrocyte precursors to neural stem cells. Genes Dev 18:
2963–2972.
44. Masui T, Wakefield LM, Lechner JF, LaVeck MA, Sporn MB, et al. (1986)
Type beta transforming growth factor is the primary differentiation-inducing
serum factor for normal human bronchial epithelial cells. Proc Natl Acad
Sci U S A 83: 2438–2442.
45. Smith AN, Miller LA, Radice G, Ashery-Padan R, Lang RA (2009) Stage-
dependent modes of Pax6-Sox2 epistasis regulate lens development and eye
morphogenesis. Development 136: 2977–2985.
46. Ji H, Houghton AM, Mariani TJ, Perera S, Kim CB, et al. (2006) K-ras
activation generates an inflammatory response in lung tumors. Oncogene 25:
2105–2112.
47. Wan H, Kaestner KH, Ang SL, Ikegami M, Finkelman FD, et al. (2004) Foxa2
regulates alveolarization and goblet cell hyperplasia. Development 131:
953–964.
48. Sinner D, Kordich JJ, Spence JR, Opoka R, Rankin S, et al. (2007) Sox17 and
Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation
of colon carcinoma cells. Mol Cell Biol 27: 7802–7815.
49. Kretzschmar M, Doody J, Timokhina I, Massague J (1999) A mechanism of
repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev 13:
804–816.
50. Besnard V, Xu Y, Whitsett JA (2007) Sterol response element binding protein
and thyroid transcription factor-1 (Nkx2.1) regulate Abca3 gene expression.
Am J Physiol Lung Cell Mol Physiol 293: L1395–1405.
51. Zhang L, Whitsett JA, Stripp BR (1997) Regulation of Clara cell secretory
protein gene transcription by thyroid transcription factor-1. Biochim Biophys
Acta 1350: 359–367.
52. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, et al. (2004)
Immortalization of human bronchial epithelial cells in the absence of viral
oncoproteins. Cancer Res 64: 9027–9034.
Sox2 Regulates Progenitors
PLoS ONE | www.plosone.org 12 December 2009 | Volume 4 | Issue 12 | e8248